Advertisement
Screener

PAR PHARMACEUTICAL COMPANIES, INC. Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31)

PAR PHARMACEUTICAL COMPANIES, INC. Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31)

PAR PHARMACEUTICAL COMPANIES, INC. reported Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) of $43.60 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-02.

Discontinued › Notes › Equity

us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount · last filed 2012-08-02

  • PAR PHARMACEUTICAL COMPANIES, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2012-06-30 was $43.60M.
  • PAR PHARMACEUTICAL COMPANIES, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2012-03-31 was $43.60M.
  • PAR PHARMACEUTICAL COMPANIES, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2011-12-31 was $0.00.
  • PAR PHARMACEUTICAL COMPANIES, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2011-09-30 was $0.00.
  • PAR PHARMACEUTICAL COMPANIES, INC. stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for fiscal 2011 was $43.60M.
Period endStock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 1 monthStock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 3 monthStock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 6 monthStock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 9 monthStock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 12 month
2012-06-30$43.60M
10-Q · filed 2012-08-02
$87.20M
derived: sum of 2 quarters · filed 2012-08-02
$87.20M
derived: sum of 3 quarters · filed 2012-08-02
$87.20M
derived: sum of 4 quarters · filed 2012-08-02
2012-03-31$43.60M
10-Q · filed 2012-05-08
$43.60M
derived: sum of 2 quarters · filed 2012-05-08
$43.60M
derived: sum of 3 quarters · filed 2012-05-08
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28
$0.00
derived: sum of 2 quarters · filed 2012-02-28
$43.60M
10-K · filed 2012-02-28
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
$43.60M
10-Q · filed 2011-11-02
2011-06-30$43.60M
10-Q · filed 2011-08-03
2007-09-30$17.80M
10-K · filed 2012-02-28